info@shukrapharmaceuticals.com
+91 79 48981130
In a landmark moment for Indian healthcare, Shukra Pharmaceuticals Ltd. and Borns Medical Robotics Inc. formally entered a strategic partnership through a Memorandum of Understanding (MOU) on February 5, 2026, in New Delhi.
This collaboration marks a significant stride in the "Make in India" initiative, aiming to indigenize advanced surgical technology. The event saw participation from leading doctors from across India who had experienced the VEER robotic system firsthand.
Mr. Dakshesh Shah, CMD of Shukra Pharmaceuticals Ltd., opened with a powerful vision: "Every human being deserves advanced technology." He framed the partnership as a crucial step in democratizing global medical advancements, making them accessible to all societal strata and actively fostering national self-reliance in cutting-edge healthcare innovation.
CMD, Shukra Pharmaceuticals Ltd.
CEO & Global Head, Shukra Pharmaceuticals
Dr. Minakshi Late, Group CEO & Global Head, detailed the mission's core pillars: uncompromising quality, affordability, and accessibility. She championed robotic surgery as a transformative point-of-care innovation for the future. This vision directly aligns with national healthcare priorities to establish advanced robotic surgery as a cornerstone of India's medical landscape.
Founder and CEO, Borns Medical Robotics Inc.
We envision a world where every surgeon, in any operating room, is empowered by intuitive robotic assistance. Our mission is to make this advanced standard of care universally accessible, turning today's cutting-edge innovation into tomorrow's routine practice. This standard isn't defined by technology for its own sake, but by the human outcomes it enables: smaller incisions, reduced trauma, shorter hospital stays, and a faster return to life. At borns medical robotics inc., we measure our success by your recovery.
CMO, Borns Medical Robotics Inc.
Dr. Alexander Tobias Teichmann, CMO of Borns Medical Robotics Inc., presented the VEER robotic surgery platform, highlighting its precision, efficiency, and transformative potential in modern healthcare. Speaking with conviction, he stated, "Robotics is the future of surgery," emphasizing how advanced robotic systems will redefine surgical outcomes and elevate patient care standards worldwide.
Senior Director & Head – Max Institute of Minimal Access, Bariatric & Robotic Surgery
Dr. Bindal, highlighted VEER's exceptional precision and its potential to redefine surgical excellence in India. He emphasized how the platform empowers surgeons with enhanced control, accuracy, and confidence, ultimately leading to improved patient outcomes and setting new benchmarks for advanced surgical care across the country.
The partnership between Shukra Pharmaceuticals and Borns Medical Robotics represents more than a business agreement—it's a commitment to advancing healthcare accessibility across India.
By bringing world-class robotic surgery technology to Indian hospitals at an affordable cost, this collaboration aims to democratize advanced surgical care and position India as a global leader in medical technology innovation.
